Spinal and Bulbar Muscular Atrophy Latest Advances

Generalized Myasthenia Gravis with Anti-acetylcholine Receptor Antibodies during the Clinical Course of Spinal and Bulbar Muscular Atrophy: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: December 03, 2025

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: October 10, 2025

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

Journal: Rinsho shinkeigaku = Clinical neurology

Published: September 28, 2025

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Journal: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

Published: September 22, 2025

Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.

Journal: Journal of neurology

Published: September 13, 2025

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Journal: European review for medical and pharmacological sciences

Published: September 04, 2025

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Journal: Zhonghua nei ke za zhi

Published: September 04, 2025

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

Journal: BMJ case reports

Published: August 04, 2025

Bone Fragility and Fracture Characteristics in Patients With Spinal and Bulbar Muscular Atrophy.

Journal: European journal of neurology

Published: July 27, 2025

Exosome-rich mesenchymal stem cell secretome improves strength in patients with amyotrophic lateral sclerosis, Kennedy disease, congenital myasthenic syndrome and Lewy body dementia.

Journal: American journal of stem cells

Published: June 09, 2025

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

Journal: International journal of molecular sciences

Published: June 09, 2025

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: June 04, 2025

Filters

Generalized Myasthenia Gravis with Anti-acetylcholine Receptor Antibodies during the Clinical Course of Spinal and Bulbar Muscular Atrophy: A Case Report.

Generalized Myasthenia Gravis with Anti-acetylcholine Receptor Antibodies during the Clinical Course of Spinal and Bulbar Muscular Atrophy: A Case Report.

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

Targeting the mutant androgen receptor with PROTACs in spinal and bulbar muscular atrophy.

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

A case of spinal and bulbar muscular atrophy with acute bilateral vocal cord paralysis suddenly apparent after infection

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Best practice recommendations for the clinical care of spinal bulbar muscular atrophy.

Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.

Therapeutic impact of leuprorelin acetate on spinal and bulbar muscular atrophy: pre- and post-marketing observational study.

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Multi-system involvement characteristics and influencing factors of disease progression in Kennedy's disease

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

Spinal and bulbar muscular atrophy with hand tremors and chronic limb weakness, Kennedy disease.

Bone Fragility and Fracture Characteristics in Patients With Spinal and Bulbar Muscular Atrophy.

Bone Fragility and Fracture Characteristics in Patients With Spinal and Bulbar Muscular Atrophy.

Exosome-rich mesenchymal stem cell secretome improves strength in patients with amyotrophic lateral sclerosis, Kennedy disease, congenital myasthenic syndrome and Lewy body dementia.

Exosome-rich mesenchymal stem cell secretome improves strength in patients with amyotrophic lateral sclerosis, Kennedy disease, congenital myasthenic syndrome and Lewy body dementia.

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

Neuroaxonal Degeneration as a Converging Mechanism in Motor Neuron Diseases (MNDs): Molecular Insights into RNA Dysregulation and Emerging Therapeutic Targets.

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.

PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models.